{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:12:56Z","timestamp":1791295976091,"version":"4.1.0"},"reference-count":46,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Previous studies have demonstrated that sickle cell disease (SCD) can be corrected in mouse models by transduction of hematopoietic stem cells with lentiviral vectors containing anti-sickling globin genes followed by transplantation of these cells into syngeneic recipients. Although self-inactivating (SIN) lentiviral vectors with or without insulator elements should provide a safe and effective treatment in humans, some concerns about insertional mutagenesis persist. An ideal correction would involve replacement of the sickle globin gene (\u03b2S) with a normal copy of the gene (\u03b2A). We recently derived embryonic stem (ES) cells from a novel knockin mouse model of SCD and tested a protocol for correcting the sickle mutation by homologous recombination. Animals derived after gene replacement produced high levels of normal human hemoglobin (HbA), and the pathology associated with SCD was corrected. These experiments provided a foundation for similar studies in which our group collaborated with Rudolf Jaenisch\u2019s laboratory to correct SCD by gene replacement in iPS (induced pluripotent stem) cells derived by direct reprogramming of sickle skin fibroblasts. Corrected iPS cells were differentiated into hematopoeitic progenitors that were transplanted into irradiated sickle recipients. The transplanted animals produced high levels of normal human HbA, and the pathology of SCD was corrected. These proof-of-principle studies provide a foundation for the development of gene replacement therapy for human patients with SCD and other blood disorders.<\/jats:p>","DOI":"10.1182\/asheducation-2008.1.193","type":"journal-article","created":{"date-parts":[[2008,12,11]],"date-time":"2008-12-11T15:12:58Z","timestamp":1229008378000},"page":"193-196","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":21,"title":["Gene Replacement Therapy for Sickle Cell Disease and Other Blood Disorders"],"prefix":"10.1182","volume":"2008","author":[{"given":"Tim M.","family":"Townes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111708484340100_R1","doi-asserted-by":"crossref","unstructured":"Ingram VM. A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin. Nature. 1956;178:792\u2013794.","DOI":"10.1038\/178792a0"},{"key":"2019111708484340100_R2","doi-asserted-by":"crossref","unstructured":"Ingram VM. Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin. Nature. 1957;180:326\u2013328.","DOI":"10.1038\/180326a0"},{"key":"2019111708484340100_R3","unstructured":"Padlan EA, Love WE. Refined crystal structure of deoxyhemoglobin S. II. Molecular interactions in the crystal. J Biol Chem. 1985;260:8280\u20138291."},{"key":"2019111708484340100_R4","doi-asserted-by":"crossref","unstructured":"Wishner BC, Ward KB, Lattman EE, Love WE. Crystal structure of sickle-cell deoxyhemoglobin at 5 A resolution. J Mol Biol. 1975;98:179\u2013194.","DOI":"10.1016\/S0022-2836(75)80108-2"},{"key":"2019111708484340100_R5","doi-asserted-by":"crossref","unstructured":"Brittenham GM, Schechter AN, Noguchi CT. Hemoglobin S polymerization: primary determinant of the hemolytic and clinical severity of the sickling syndromes. Blood. 1985;65:183\u2013189.","DOI":"10.1182\/blood.V65.1.183.183"},{"key":"2019111708484340100_R6","doi-asserted-by":"crossref","unstructured":"Crepeau RH, Dykes G, Garrell R, Edelstein SJ. Diameter of haemoglobin S fibres in sickled cells. Nature. 1978;274:616\u2013617.","DOI":"10.1038\/274616a0"},{"key":"2019111708484340100_R7","doi-asserted-by":"crossref","unstructured":"Dykes GW, Crepeau RH, Edelstein SJ. Three-dimensional reconstruction of the 14-filament fibers of hemoglobin S. J Mol Biol. 1979;130:451\u2013472.","DOI":"10.1016\/0022-2836(79)90434-0"},{"key":"2019111708484340100_R8","doi-asserted-by":"crossref","unstructured":"Eaton WA, Hofrichter J. Hemoglobin S gelation and sickle cell disease. Blood. 1987;70:1245\u20131266.","DOI":"10.1182\/blood.V70.5.1245.1245"},{"key":"2019111708484340100_R9","doi-asserted-by":"crossref","unstructured":"Frenette PS, Atweh GF. Sickle cell disease: old discoveries, new concepts, and future promise. J Clin Invest. 2007;117:850\u2013858.","DOI":"10.1172\/JCI30920"},{"key":"2019111708484340100_R10","doi-asserted-by":"crossref","unstructured":"Hebbel RP. Adhesion of sickle red cells to endothelium: myths and future directions. Transfus Clin Biol. 2008;15:14\u201318.","DOI":"10.1016\/j.tracli.2008.03.011"},{"key":"2019111708484340100_R11","doi-asserted-by":"crossref","unstructured":"Hofrichter J, Ross PD, Eaton WA. Kinetics and mechanism of deoxyhemoglobin S gelation: a new approach to understanding sickle cell disease. Proc Natl Acad Sci U S A. 1974;71:4864\u20134868.","DOI":"10.1073\/pnas.71.12.4864"},{"key":"2019111708484340100_R12","doi-asserted-by":"crossref","unstructured":"Krajewski ML, Hsu LL, Gladwin MT. The proverbial chicken or the egg? Dissection of the role of cell-free hemoglobin versus reactive oxygen species in sickle cell pathophysiology. Am J Physiol Heart Circ Physiol. 2008;295:H4\u20137.","DOI":"10.1152\/ajpheart.00499.2008"},{"key":"2019111708484340100_R13","doi-asserted-by":"crossref","unstructured":"Noguchi CT, Schechter AN. The intracellular polymerization of sickle hemoglobin and its relevance to sickle cell disease. Blood. 1981;58:1057\u20131068.","DOI":"10.1182\/blood.V58.6.1057.bloodjournal5861057"},{"key":"2019111708484340100_R14","doi-asserted-by":"crossref","unstructured":"Taylor JG 4th, Nolan VG, Mendelsohn L, Kato GJ, Gladwin MT, Steinberg MH. Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive pain. PLoS ONE. 2008;3:e2095.","DOI":"10.1371\/journal.pone.0002095"},{"key":"2019111708484340100_R15","doi-asserted-by":"crossref","unstructured":"Wood KC, Hsu LL, Gladwin MT. Sickle cell disease vasculopathy: a state of nitric oxide resistance. Free Radic Biol Med. 2008;44:1506\u20131528.","DOI":"10.1016\/j.freeradbiomed.2008.01.008"},{"key":"2019111708484340100_R16","doi-asserted-by":"crossref","unstructured":"Zennadi R, De Castro L, Eyler C, Xu K, Ko M, Telen MJ. Role and regulation of sickle red cell interactions with other cells: ICAM-4 and other adhesion receptors. Transfus Clin Biol. 2008;15:23\u201328.","DOI":"10.1016\/j.tracli.2008.04.009"},{"key":"2019111708484340100_R17","doi-asserted-by":"crossref","unstructured":"Behringer RR, Ryan TM, Palmiter RD, Brinster RL, Townes TM. Human gamma- to beta-globin gene switching in transgenic mice. Genes Dev. 1990;4:380\u2013389.","DOI":"10.1101\/gad.4.3.380"},{"key":"2019111708484340100_R18","doi-asserted-by":"crossref","unstructured":"Ryan TM, Ciavatta DJ, Townes TM. Knockout-transgenic mouse model of sickle cell disease. Science. 1997;278:873\u2013876.","DOI":"10.1126\/science.278.5339.873"},{"key":"2019111708484340100_R19","doi-asserted-by":"crossref","unstructured":"Ryan TM, Townes TM, Reilly MP, et al. Human sickle hemoglobin in transgenic mice. Science. 1990;247:566\u2013568.","DOI":"10.1126\/science.2154033"},{"key":"2019111708484340100_R20","doi-asserted-by":"crossref","unstructured":"Gaensler KM, Kitamura M, Kan YW. Germ-line transmission and developmental regulation of a 150-kb yeast artificial chromosome containing the human beta-globin locus in transgenic mice. Proc Natl Acad Sci U S A. 1993;90:11381\u201311385.","DOI":"10.1073\/pnas.90.23.11381"},{"key":"2019111708484340100_R21","doi-asserted-by":"crossref","unstructured":"Greaves DR, Fraser P, Vidal MA, et al. A transgenic mouse model of sickle cell disorder. Nature. 1990;343:183\u2013185.","DOI":"10.1038\/343183a0"},{"key":"2019111708484340100_R22","doi-asserted-by":"crossref","unstructured":"Kaufman RM, Pham CT, Ley TJ. Transgenic analysis of a 100-kb human beta-globin cluster-containing DNA fragment propagated as a bacterial artificial chromosome. Blood. 1999;94:3178\u20133184.","DOI":"10.1182\/blood.V94.9.3178"},{"key":"2019111708484340100_R23","doi-asserted-by":"crossref","unstructured":"Paszty C, Brion CM, Manci E, et al. Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science. 1997;278:876\u2013878.","DOI":"10.1126\/science.278.5339.876"},{"key":"2019111708484340100_R24","doi-asserted-by":"crossref","unstructured":"Peterson KR, Clegg CH, Huxley C, et al. Transgenic mice containing a 248-kb yeast artificial chromosome carrying the human beta-globin locus display proper developmental control of human globin genes. Proc Natl Acad Sci U S A. 1993;90:7593\u20137597.","DOI":"10.1073\/pnas.90.16.7593"},{"key":"2019111708484340100_R25","doi-asserted-by":"crossref","unstructured":"Strouboulis J, Dillon N, Grosveld F. Developmental regulation of a complete 70-kb human beta-globin locus in transgenic mice. Genes Dev. 1992;6:1857\u20131864.","DOI":"10.1101\/gad.6.10.1857"},{"key":"2019111708484340100_R26","doi-asserted-by":"crossref","unstructured":"Levasseur DN, Ryan TM, Pawlik KM, Townes TM. Correction of a mouse model of sickle cell disease: lentiviral\/antisickling beta-globin gene transduction of unmobilized, purified hematopoietic stem cells. Blood. 2003;102:4312\u20134319.","DOI":"10.1182\/blood-2003-04-1251"},{"key":"2019111708484340100_R27","doi-asserted-by":"crossref","unstructured":"Pawliuk R, Westerman KA, Fabry ME, et al. Correction of sickle cell disease in transgenic mouse models by gene therapy. Science. 2001;294:2368\u20132371.","DOI":"10.1126\/science.1065806"},{"key":"2019111708484340100_R28","doi-asserted-by":"crossref","unstructured":"Puthenveetil G, Scholes J, Carbonell D, et al. Successful correction of the human beta-thalassemia major phenotype using a lentiviral vector. Blood. 2004;104:3445\u20133453.","DOI":"10.1182\/blood-2004-04-1427"},{"key":"2019111708484340100_R29","doi-asserted-by":"crossref","unstructured":"Imren S, Fabry ME, Westerman KA, et al. High-level beta-globin expression and preferred intragenic integration after lentiviral transduction of human cord blood stem cells. J Clin Invest. 2004;114:953\u2013962.","DOI":"10.1172\/JCI200421838"},{"key":"2019111708484340100_R30","doi-asserted-by":"crossref","unstructured":"Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003;302:415\u2013419.","DOI":"10.1126\/science.1088547"},{"key":"2019111708484340100_R31","doi-asserted-by":"crossref","unstructured":"Seggewiss R, Pittaluga S, Adler RL, et al. Acute myeloid leukemia associated with retroviral gene transfer to hematopoietic progenitor cells of a rhesus macaque. Blood. 2006;107:3865\u20133867.","DOI":"10.1182\/blood-2005-10-4108"},{"key":"2019111708484340100_R32","doi-asserted-by":"crossref","unstructured":"Wu LC, Sun CW, Ryan TM, Pawlik KM, Ren J, Townes TM. Correction of sickle cell disease by homologous recombination in embryonic stem cells. Blood. 2006;108:1183\u20131188.","DOI":"10.1182\/blood-2006-02-004812"},{"key":"2019111708484340100_R33","doi-asserted-by":"crossref","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663\u2013676.","DOI":"10.1016\/j.cell.2006.07.024"},{"key":"2019111708484340100_R34","doi-asserted-by":"crossref","unstructured":"Blelloch R, Venere M, Yen J, Ramalho-Santos M. Generation of induced pluripotent stem cells in the absence of drug selection. Cell Stem Cell. 2007;1:245\u2013247.","DOI":"10.1016\/j.stem.2007.08.008"},{"key":"2019111708484340100_R35","doi-asserted-by":"crossref","unstructured":"Maherali N, Sridharan R, Xie W, et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell. 2007;1:55\u201370.","DOI":"10.1016\/j.stem.2007.05.014"},{"key":"2019111708484340100_R36","doi-asserted-by":"crossref","unstructured":"Meissner A, Wernig M, Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol. 2007;25:1177\u20131181.","DOI":"10.1038\/nbt1335"},{"key":"2019111708484340100_R37","doi-asserted-by":"crossref","unstructured":"Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007;448:313\u2013317.","DOI":"10.1038\/nature05934"},{"key":"2019111708484340100_R38","doi-asserted-by":"crossref","unstructured":"Wernig M, Meissner A, Foreman R, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature. 2007;448:318\u2013324.","DOI":"10.1038\/nature05944"},{"key":"2019111708484340100_R39","doi-asserted-by":"crossref","unstructured":"Hanna J, Wernig M, Markoulaki S, et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science. 2007;318:1920\u20131923.","DOI":"10.1126\/science.1152092"},{"key":"2019111708484340100_R40","doi-asserted-by":"crossref","unstructured":"Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861\u2013872.","DOI":"10.1016\/j.cell.2007.11.019"},{"key":"2019111708484340100_R41","doi-asserted-by":"crossref","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917\u20131920.","DOI":"10.1126\/science.1151526"},{"key":"2019111708484340100_R42","doi-asserted-by":"crossref","unstructured":"Park IH, Zhao R, West JA, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 2008;451:141\u2013146.","DOI":"10.1038\/nature06534"},{"key":"2019111708484340100_R43","doi-asserted-by":"crossref","unstructured":"Lowry WE, Richter L, Yachechko R, et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A. 2008;105:2883\u20132888.","DOI":"10.1073\/pnas.0711983105"},{"key":"2019111708484340100_R44","doi-asserted-by":"crossref","unstructured":"Murry CE, Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell. 2008;132:661\u2013680.","DOI":"10.1016\/j.cell.2008.02.008"},{"key":"2019111708484340100_R45","doi-asserted-by":"crossref","unstructured":"Zwaka TP, Thomson JA. Homologous recombination in human embryonic stem cells. Nat Biotechnol. 2003;21:319\u2013321.","DOI":"10.1038\/nbt788"},{"key":"2019111708484340100_R46","doi-asserted-by":"crossref","unstructured":"Ying QL, Wray J, Nichols J, et al. The ground state of embryonic stem cell self-renewal. Nature. 2008;453:519\u2013523.","DOI":"10.1038\/nature06968"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2008\/1\/193\/786499\/193_196ash.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2008\/1\/193\/786499\/193_196ash.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T13:49:02Z","timestamp":1573998542000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2008\/1\/193\/95825\/Gene-Replacement-Therapy-for-Sickle-Cell-Disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1,1]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2008.1.193","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,1]]}}}